3D Bioprinting for Skin (Premium)

Skin and its derivatives of hair follicles, nails, sweat, and oil glands play a myriad of important roles within our body. Since the skin comes into direct contact with the outside world, it is highly susceptible to cuts, abrasions, and burns. Although the skin has a higher regenerative capacity than most tissues, the repair of large-scale deep injuries, such as deep burns, is mainly scar repair. The current standard of care for patients with severe large area skin defects consists of autologous skin grafting or dermal substitutes. However, the shortage of donor skin sites and infection risks limit the application of grafts and emerging dermal substitutes still face challenges in delivering cells to clinically relevant wound topologies and the promotion of vascularization. The 3D bioprinting of skin models has garnered increasing research interest in recent years due to the potential in disease modeling, testing the efficacy of new treatments, and providing alternatives to animal testing. Continued developments in 3D bioprinting skin equivalents show promise in defining the composition of biomaterials, cells, and bioactive factors for accelerated wound regeneration.


Abbas Shafiee

Dr Abbas Shafiee is a tissue engineering & regenerative medicine scientist interested in translational cell-based and tissue engineering strategies to treat human diseases. 

Dr Shafiee completed his PhD at The University of Queensland on stem cell biology. His research career during his PhD had key contributions to delineating endothelial niche and vascular stem cells in the human placental tissues, including the seminal discovery of an entirely new stem cell population, coined as ‘Meso-Endothelial Bipotent Progenitor’ and the identification of key driver signatures for endothelial and bipotential progenitor function. Post-PhD, he joined Queensland University of Technology and conducted multiple projects on cancer and bone tissue engineering. Dr Shafiee has developed innovative tissue engineered models intersecting concepts from stem cell biology, cancer, and tissue engineering to study species-specific cancer bone metastasis at an unprecedented level of detail. Utilizing the tissue engineering concept, he was able to better understand the mechanisms of cancer bone metastasis. Additionally, he was successful in obtaining project grants, and developed a biomimetically designed scaffolds and investigated the interactions of multipotent mesenchymal stem/stromal cell and skin progenitors with 3D printed scaffolds. 

Dr Shafiee joined Herston Biofabrication Institute (HBI, MNHHS, Brisbane) in 2020 and started a research program to develop, implement, and evaluate the applications of 3D printing, scanning, cell therapies, and biofabrication technologies in skin wound settings. Using 3D printing and stem/progenitor cell delivery he could develop new approaches to enhances physiological wound closure with reduced scar tissue formation. He is also is part of a national program aiming to develop 3D bioprinting technology to treat skin wounds.

Colin McGuckin

Colin was the UK’s first Full Professor of Regenerative Medicine, before Founding CTIBIOTECH to create not only organ-based models for drug screening and efficacy testing, but also to create cell and organ therapies of the future. Coming from a background of Hematology / Oncology his work expanded in the 1990’s to stem cells and his academic group were first in the world to create neural and hepatic tissues from adult stem cells. Now at CTIBIOTECH they are leaders in 3D bioprinting models of the human body, with a lot of success in complex skin, tumors and liver systems.

Axel Guenther

Professor, University of Toronto

Dr. Guenther is a Full Professor in the Department of Mechanical and Industrial Engineering, with cross-appointment at the Institute of Biomedical Engineering at the University of Toronto. He obtained his doctoral degree from ETH Zurich and conducted postdoctoral research at the Massachusetts Institute of Technology. He received the ETH medal (2002), the Ontario Early Researcher Award (2009), the I.W. Smith Award of the Canadian Society of Mechanical Engineers (2010) and the Innovator of the Year (2013) and Safwat Zaky Research Leader (2021) Awards of the University of Toronto. He is interested in microfluidic and biofabrication strategies for hierarchical biomaterials and tissues. He invented several bioprinting technologies and currently serves as the founding Co-Director of the nationally unique Centre for Research and Applications in Fluidic Technologies (CRAFT), a collaborative research center between the University of Toronto and the National Research Council of Canada (NRC) that aims to accelerate the translation of microfluidic device innovations to industry and to the clinic.

Amaris Castanon

Field Application Specialist at CELLINK

Amaris Castanon

Amaris Castanon completed a Bachelor of Science at the University of Texas at El Paso (UTEP) in Cellular and Molecular Biochemistry and graduated with Magna Cum Laude high honors. She then completed a Master of Science with High Honors in Stem Cell and Regenerative Medicine at The University of Sheffield in the UK, while working at the Kroto Research Institute on a bioengineering project involving regenerative medicine approaches for peripheral nerve injury repair. Amaris has a strong international background having also completed studies abroad at Graz University of Technology in Austria, where she was enrolled in graduate bioengineering courses and discovered her strong passion for regenerative medicine. She has conducted an extensive amount of international research at institutions like University of Pennsylvania (UPENN), University of Texas Medical Branch (UTMB), Universidad Autonoma de Mexico (UNAM), Graz University of Technology (TU Graz), Fraunhofer Institute of Applied Optics and Precision and Engineering in Jena, University of Barcelona, and Kroto Research Institute. Her diverse background has allowed her to obtain significant experience in many research fields including those of stem cell culture, biomaterials, and biochemistry –all fields vital to the interfaced environment that 3D bioprinting faces today. Today, Amaris is a Field Application Specialist working with the Bioprinting team at CELLINK and is proud to form part of the BICO family, committed to revolutionize medicine through bioconvergence.

Dr. Fabien Guillemot

CEO and Founder of Poietis


Dr. Fabien GUILLEMOT is a scientist-turned-entrepreneur, CEO and Founder of Poietis, whose mission is to develop and market the Next-Gen Bioprinting platform to bring Tissue Engineering therapies to patients. Fabien has an over 20 years experience in the field of Biofabrication. He holds a PhD in Material Science (INSA, 2000) and an Habilitation in Health and Life Sciences (Bordeaux University, 2010). He was appointed Researcher at INSERM, France in 2005, and invited researcher at Harvard University in 2010. Bioprinting pioneer and inventor (with 100+ publications and 13 patents), he left for entrepreneurship via training at HEC-Paris.


William Harley

William is a Ph.D. candidate within the School of Biomedical Engineering at the University of Melbourne. He obtained a certificate 3 in business management and an honors degree in medical biotechnology from the University of New South Wales where he first entered research focusing on biomaterials, stem cells, and nanofabrication processes for tissue regeneration. Currently, his Ph.D. investigates the use of acoustic micromanipulation and 3D bioprinting as tools to pattern and define the cellular microenvironment. William has held roles as a research assistant and a business development consultant, where he currently serves as a community and events manager for 3D Heals and an organizing committee member for the Australian Bioprinting Workshop.

3D Bioprinting for Food (Premium)

Lately, 3D printing food has become a hot topic, as climate change and the impending water shortage crisis all beckon humanity for alternative more environmental (and healthier) food sources. “Cultured meat”, “cellular agriculture”, “lab-grown meats” are all new popular concepts that are receiving increasing attention. What are the roles of 3D printing in all this? What are the issues entrepreneurs and scientists facing? Who are the influencers, rising startups, regulatory bodies for this emerging field? How is the culinary world receiving the 3D printing concept? 


Avery Parkinson

Avery is the Executive Director of Cellular Agriculture Canada. She has been passionate about cell ag technology for a couple of years now and has held positions at Tufts University, Big Idea Ventures, the Good Food Institute, and the Protein Report where she has worked on creating educational content and resources to grow the industry nationally and worldwide.

Kyle Von Hasseln

Kyle von Hasseln is an American inventor, entrepreneur and adventurer. He graduated Middlebury College with a focus in molecular ecology. He was awarded the Frank Gehry Prize for Best Thesis at the Southern California Institute of Architecture, where he invented and patented the first dehydrated food 3D printer. His startup, Sugar Lab, was acquired by 3D Systems where he led the development of the first NSF certified commercial food 3D printer. In 2020 he founded Culinary Printworks, the first on-demand culinary 3D printing firm, and brought back the retail Sugar Lab brand. Kyle is an avid backcountry skier, surfer, and alpine rock climber.

Roger Kuan

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Simon Fried

Simon, head of business at MeaTech, grew up around restaurants, has business experience including food retail, FMCG, distilleries and 3D printing. Combined with his academic background in risk, behavioral economics, and behavior change, he’s excited to be playing a part in the cultivated meat transformation.


Dr. Vidya Chamundeswari Narasimhan

 3DHeals Community Manager – San Francisco

Dr. Vidya is currently heading the Biomaterials engineering division at NEW AGE MEATS – Berkeley, California. She received her Ph.D from Nanyang Technological University(NTU), Singapore in 2018. Her research focused on developing bioactive polymeric scaffolds for musculoskeletal tissue regeneration applications.

During her post doctoral fellowship in Singapore, Vidya spearheaded various academia-industrial collaborative projects. At 3DHEALS, she is our Community Manager of San Francisco Bay Area and is also actively involved in STEM mentorship and in tutoring University and Junior college students for various competitive examinations.  

Vidya has been actively involved in research pertaining to sustainability within the agro-food and biomaterials sector, and is passionate about emerging technologies in the field of 3D bioprinting. She hopes to actively share and spread this interest amongst like minded professionals in the field of  regenerative medicine and tissue engineering. Currently Vidya has contributed to a couple of expert column blogs on bone tissue engineering and is the co-instructor of an online course on Bioinks used for Bioprinting available on Udemy!

3D Printing and Bioelectronics (Premium)

In this high-energy 90-minute webinar, we invite an international panel of academic and industrial experts to share their knowledge on the current status of bioelectronics, wearable devices, and other related healthcare electronic devices and explore how 3D printing can play a role.


Prof. Shweta Agarwala


Shweta Agarwala is a tenure-track assistant professor at Electrical and Computer Engine,ering, Aarhus University. Her vision is to enable component and wire-free electronic circuits that are flexible, bendable, conformable, and biodegradable. She is achieving this through material innovation and the 3D printing routes by printing electronics on unconventional substrates for next-generation electronics especially catering to the healthcare and biomedical sector. Shweta is the author of more than 40 peer-reviewed papers published in internationally renowned journals, books, and conferences. She is the vice-chair for the Women in Engineering chapter in IEEE Denmark section and an enthusiast STEM advocate. 

Amit Dror

Co-Founder & CSO Nano Dimension

An entrepreneur, Amit Dror Co-Founder and CSO of Nano Dimension, the world’s leading additive electronics provider. From 2014 to 2020 was CEO of the Nano Dimension.

Started in the Telecoms industry and spent a decade at ECI and Comverse, before co-founding his first start-up, Eternegy Ltd in 2010, which focused on solar power and environmentally friendly electricity generation.

Co-founded the Milk & Honey Whiskey Distillery. Israel’s first ever whisky distillery, the company produces each whisky to the highest standards. It was soon recognized by Forbes and nominated as one to try.

It was not long before Amit recognized a further niche in the marketplace – this time with additive electronics, and he co-founded Nano Dimension in 2012. Amit currently serves as Nano Dimension’s CEO.

Recognized as the world’s leading additive electronics provider, and a company that is disrupting, reshaping and defining the future of how cognitive, connected electronic products are made.

Amit is keenly aware that the Nano Dimension technology will soon impact the future of every industry from medical devices and telecommunications to the defense, aerospace and automotive industries, and will heavily influence our personal futures in years to come. 

Nano Dimension has an unmatched product portfolio including the unrivalled and award-winning DragonFly™ Pro System for Precision Additive Manufacturing of Printed Electronics. “This machine essentially prints simultaneously Nano-metal and complex-polymer which has never been done before. This means that electronics can be produced more quickly and securely in-house, with lower costs and disruptive designs than ever before.”

“We are enabling the electronics industry to catch up with the fast-paced world of today – and print electronics immediately and in-house. This makes our solution a cost-effective, highly efficient, and accessible way to produce the much-needed electronics proliferating through our lives today – in smaller sizes and even different shapes.”

Ashok Sridhar, PhD MBA

Ashok Sridhar is a Senior Business Development Manager at Holst Centre, a leading R&D innovation centre in the Netherlands, focusing on next-generation electronics. He is also part of the core team at Holst Centre that is involved in start-up creation. 

Ashok has deep techno-commercial expertise in additive manufacturing technologies namely Printed Electronics and 3D Printing. He is adept at identifying new growth opportunities and convincing internal stakeholders to establish innovative projects to meet customer requirements and exploit market inefficiencies. 

Ashok received his PhD in inkjet printed electronics in 2010. From then on until 2015, he developed additive manufacturing technologies for Printed Electronics, for a wide range of wearable and sensing applications – enablers of ubiquitous sensing for IoT. In the beginning of 2015, Ashok moved to a market-facing role at SABIC, identifying emerging opportunities in Printed Electronics and In-Mold Electronics. During this period, he augmented his business skills through an Executive MBA at TIAS, a top B-School in Europe, receiving a cum laude and scoring 9/10 for his thesis. Subsequently, he developed the marketing strategy for Luxexcel, the only company in the world offering 3D printing solutions for ophthalmic lenses. Later, he spent an year in India, where he setup the first full-fledged printed electronics manufacturing facility in that country, before moving back to the Netherlands to take up the present role at Holst Centre.


Jenny Chen, M.D. 

Jenny Chen, MD, is currently the Founder and CEO of 3DHEALS, a company focusing on education and industrial research in the space of bioprinting, regenerative medicine, healthcare applications using 3D printing. With a focus on emerging healthcare technology, Jenny invests in and mentors relevant startups, especially companies pitching through Pitch3D. She believes a more decentralized and personalized healthcare delivery system will better our future.


3DHEALS Ohio: Hidden Gems (Premium)

Ohio is perhaps one of the most overlooked healthcare innovation hubs. In this webinar focusing on 3DHEALS Ohio community, we are featuring experts from academia and local businesses who are working on cool things that (you may not realize) are happening in Ohio.

Speaker info:

Andrew Hudson

Andrew received his B.Sc. in Materials Science and Engineering (2014) and M.Sc. in Biomedical Engineering (2015) from Carnegie Mellon University. He is currently a Ph.D. student in Adam Feinberg’s Regenerative Biomaterials and Therapeutics Group. The goal of Andrew’s research is to vastly improve the resolution and vascularization in 3D bioprinting to create the next generation of tissue engineered therapies such as cardiac muscle. Andrew is also a Co-Founder of FluidForm, a CMU startup that seeks to spread the FRESH 3D bioprinting technology developed in the Feinberg lab. 

Interview with Andrew Hudson, Co-Founder of Fluidform

The Yellow Brick Road of 3D Bioprinting (Part 1)

The Yellow Brick Road of 3D Bioprinting (Part 2): Soft Is Hard

The Yellow Brick Road of 3D Bioprinting (Part 3): Maturation

3D Bioprinting: The Yellow Brick Road (Part 4)

Keith Grafmeyer

Keith Grafmeyer graduated from the University of Rochester with a BS in Biomedical Engineering and is currently the Director of Product Development at VisionAir Solutions, a spinout of the Cleveland Clinic.  He has been working in medical device startups in the Cleveland-area for about 6 years while holding management roles in regulatory affairs and product development.  So far in his career, Keith has brought two patient-specific medical device systems to market in orthopedics and interventional pulmonology with 7 FDA 510(k) clearances.  The orthopedic system was acquired in 2018 by Arthrex.  It has now treated tens of thousands of patients as their Arthrex VIP shoulder arthroplasty product.  

In his current role, Keith oversaw the development and product launch of a system to treat airway obstruction with proprietary software and patient-specific silicone airway stents.  The company is working on a new version of this software as well as implants to treat other complex problems in interventional pulmonology.

Overall, Keith has had the unique experience of managing the development, regulatory clearance, and market launch of products that contain proprietary software and patient-specific treatment deliverables manufactured using 3D-printing technology.

Dave Pierson

Senior Design engineer at Manufacturing Advocacy & Growth Network (MAGNET)

Dave Pierson

Dave Pierson is a Senior Design Engineer for MAGNET and a notable figure in the advanced manufacturing community. He has 23 years of varied and practical additive manufacturing training experience as well as 40 years of experience in mechanical and electric engineering and programming. Pierson regularly develops and delivers training curriculum and trains operators, students, and engineers on past and present additive techniques. His experience covers seven AM standards categories as set by the American Society for Testing and Materials.

David Dean

Departments of Plastic and Reconstructive Surgery and Materials Science and Engineering at The Ohio State University

David Dean

David Dean’s research focuses on medical procedures and devices primarily related to musculoskeletal reconstructive surgery. His PhD thesis presented a novel, template-based method for the production of average 3D surface images of organs such as the skull. His postdoctoral research at the Institute of Reconstructive and Plastic Surgery (New York University, New York, NY) used average skull images as targets for surgical simulation and intra-operative guidance. In July 1994, Dr. Dean joined Case Western Reserve University (Cleveland, OH) where he began using average skull images to design and fabricate cranial implants in the Department of Neurological Surgery. Indeed, Dr. Dean was the first person to use an anatomical template to design and 3D print a patient-specific cranial implant, a procedure that is now standard-of-care. Since the mid-1990’s Dr. Dean’s research has expanded to incorporate techniques from the field of regenerative medicine, including biomaterials, skeletal progenitor cells, and cell-signaling proteins and molecules in the search for a bone tissue engineering (i.e., bone substitute) strategy. In 2013 Dr. Dean’s primary appointment moved to the Department of Plastic and Reconstructive Surgery at The Ohio State University (Columbus, OH) and, currently, the Materials Science and Engineering Department. At Ohio State University he leads the Osteo Engineering Lab ( where novel bone tissue engineering research uses 3D printed, resorbable, solid-cured polymers as well as bioprinted, cell-laden, hydrogels. He is also working on the 3D printing of two biometals, NiTi and a resorbable, patent-pending Mg alloy. Both are being used to develop stiffness-matched, skeletal fixation devices. Taken together, these technologies portend significant improvements in musculoskeletal reconstructive surgical outcomes.


Dr. Justin Baker

Dr. Justin Baker

Dr. Justin Baker graduated magna cum laude and with university honors in mechanical engineering from Brigham Young University (BYU). Dr. Baker subsequently earned his Ph.D. in Bioengineering from the University of Utah. A postdoctoral fellowship at the Cleveland Clinic brought him and his family to Cleveland in 2010. Since then Dr. Baker has worked for a number of local start-up and mid-size medical device companies, and his family has grown to include six children. In 2014, Dr. Baker was certified in Regulatory Affairs (RAC). He currently serves as the Vice President for Research and Development for Viscus Biologics, collagen, and natural polymers-based biomaterials and medical device company. Dr. Baker has been the Cleveland Community Manager for 3DHEALS since 2018.

3DHeals Melbourne – 3D MedTech Innovation (Premium)

3DHeals Melbourne is returning in 2021 to highlight local collaborative innovations in health care 3D technologies and to provide a virtual platform to foster crosstalk between clinicians, academia, and industry. The focus for this event will be on the real-world applications of biomedical engineering as we will hear from leading experts in the fields of 3D printing, 3D modeling/digital design, medical devices, and implants, followed by a discussion panel to breakdown similar challenges that lie ahead and how best to synergize research and development efforts moving forward. 

3DHeals Melbourne welcomes all who are interested to learn more of the latest developments, practical applications, and future explorations of these exciting 3D medical technologies and how they can help shape the future of patient care.

Speaker info:

William Harley

William Harley

William Harley graduated with honors in medical biotechnology from the University of New South Wales. Currently, he is undertaking a Ph.D. at the University of Melbourne in acoustophoretic bioprinting. Stemming from his research experience in biomaterials, stem cells, and nanofabrication, he is driven by the clinical translation of personalized regenerative medicine. He is passionate about the innovation of 3D printing in healthcare and is determined to orchestrate a series of 3D HEALS events to engage in the Australian community.

Mark Roe

Managing Director of Fusetec

Mark Roe

Mark Roe, along with his business partner John Budgen founded Fusetec in April 2017, the business had a somewhat unconventional beginning. “When I was introduced to advanced manufacturing, the theory behind Industry 4.0 was compelling. I could really see a future in it,” said Roe. Once back in Australia, Mark considered the three major manufacturing industries in South Australia: aerospace, defense, and medical. He quickly landed on medical. “By opting to work in the medical industry, we could develop our own IP, with global applications.” It was then that he started canvassing medical professionals and academia to pinpoint that all-elusive problem to solve. The three most commonly cited issues were a lack of cutting guides, medical implants, and patient-specific models. However, he was not keen to pursue a business model based on personalized manufacturing. Mark leads the management team and passionately drives our Research & Development team, collaborating with Universities, Medical professionals, and Government entities worldwide.

Prof. Peter Lee

Professor in the Department of Mechanical Engineering at University of Melbourne/Director of ARC CMIT

Prof. Peter Lee obtained his BEng in Mechanical Engineering (1st Class Hons. 1991) and PhD (1996) in Bioengineering from the University of Strathclyde, UK, and continued his post-doc in the same university from 1996–1998.

Professor Peter Lee is the Director of the Australian Research Council (ARC) Training Centre for Medical Implant Technologies and the Chief Investigator in the ARC Training Centre for Personalised Therapeutic Technologies. As Director of the ARC Training Centre for Medical Implant Technologies, he leads the largest industry-university-hospital partnership in Australia focusing on orthopaedic and maxillofacial implants to train a new generation of interdisciplinary engineers in biomechanics, materials and manufacturing for the orthopaedic and maxillofacial implant industry. He joined the University of Melbourne, Australia, as a Senior Lecturer in 2008, and was promoted to an Associate Professor in 2011 and a Professor in 2015. Since then he has held several leadership positions including Deputy Head and Acting Head of Department of Mechanical Engineering, and currently as the Deputy Head (Research) of Department of Biomedical Engineering and leads the Cell and Tissue Biomechanics Laboratory in Engineering, where his research aims to better understand the behaviour of biological cells and tissues under mechanical forces. He has authored more than 140 publications in journals, conference proceedings and books. He is a regular reviewer for journals and grant bodies and currently the Deputy Editor for Journal of Orthopaedic Surgery and Research (Springer Nature), and Associate Editor for Frontiers in Pharmacology (Translational Pharmacology).

A/Prof. Kate Fox

Associate Dean of Higher Degrees by Research/ and Associate Professor within the School of Electrical and Biomedical Engineering at RMIT

Kate Fox is an Associate Professor in the School of Electrical and Biomedical Engineering. Kate is a biomedical engineer with significant experience and expertise in coatings and implant fabrication for orthopedic applications. Prior to joining RMIT, she was part of the Bionic Eye Project working to develop a high acuity diamond electrode capable of electrically stimulating retinal tissue. She is a reformed patent attorney and can advise on the patentability of research. Kate is committed to the real-world application of biomedical engineering and was shortlisted for the AFR 2018 Emerging Leader in Higher Education Award. Kate is experienced in working in highly complex, transdisciplinary projects, coordinating research teams, and providing the surgical integration necessary to transition an engineered product into a surgically feasible product. She has successfully attained over A$6M direct and in-kind funding. Kate is CI in the ARC ITTC in Additive Biomanufacturing and a 2019-2020 Superstar of STEM.

Dr. Lindsay Bussau BSc (Hons), PhD

Applications and Customer Support Manager, Optiscan Pty Ltd

The talk will discuss endomicroscopy and the basics of Optiscan’s handheld fibre-optic confocal microscope. Dr. Bussau will demonstrate the Optiscan FIVE2 (Viewnvivo) handheld confocal imaging system and will discuss the potential for use of confocal endomicroscopy to image tissue structure in vivo. Dr Bussau did his post-doctorate research on confocal laser fiber optic imaging and has 25 years of experience with the technology.

Dr. Yunlong Tang

Joint lecturer in the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering Monash University

Dr. Yunlong Tang joined the Faculty of Engineering at Monash University in Feb 2020. Currently, he is a lecturer jointly appointed by the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering.  His major research interests are in the general field of design and manufacturing, including smart manufacturing, additive manufacturing, and its related design methods, sustainable design and manufacturing, AI-aided design, CAD/CAM, design and fabrication of lattice or cellular materials. Yunlong has over nine years of international R&D experience, participating in several national research and industrial projects from China, Canada, Europe, and Singapore. He obtained his Ph.D. degree from McGill University, Canada in 2017, M.Sc. degree from Beijing University of Aeronautics and Astronautics, China in 2013, B.Sc. degree from Harbin Institute of Technology in 2010. Before he coming to Monash, he did one and half year Post-Doc research at Singapore University of Technology and Design and was working on the next generation of CAD software for AM. He is a leading developer of an open-source lattice structure design and optimization software called INTRALATTICE PRO which has been downloaded more than ten thousand times by now.

Tam C. Nguyen

Associate Professor and Deputy Director of Research at St Vincent’s Hospital Melbourne

Associate Professor Tam Nguyen has over 20 years of working in the healthcare, health & medical research environment including tertiary teaching hospitals and research institute across Australia.

Tam is the Deputy Director of Research at St Vincent’s Hospital Melbourne, one of the largest tertiary teaching and research hospitals in Melbourne – responsible for the organisation’s research strategy, research ethics and governance, clinical trials, research innovation and development.

Tam serves as non-executive director and advises several medtech and health tech start-ups on clinical and commercialisation strategy. He is a regular invited speaker on a broad range of topics at national and international conferences. He holds academic appointment with Melbourne University’s Medical School and Monash University’s Medical School – two of the world top 30 (and APAC top 5) medical schools.



3DHEALS2020 Summit Recordings (Premium)


3DHEALS2020 (June 5th-6th, 2020 )was the largest virtual summit this year, in the space of healthcare 3D printing/bioprinting, or elsewhere. This incredible virtual two-day summit gathered more than 70 world experts, 22sessions. It is one of the most well-curated events that engage the audience to learn, think, and re-invent future healthcare.

We believe the recordings of this summit not long serve as a record of technological advanced in time and space, but also a good starting point for anyone who is interested in working and investing in this unique space.

Download Agenda here:

3D Printing Ti6Al4V Orthopaedic Implants: As Easy as Counting 1-2-3 (Video)

Media Coverage:

3DHEALS2020: Thank You!

Adventure for Life: Why You Really Should “Attend” 3DHEALS2020 Live

3DHEALS 2020 Virtual Medical Summit: 3D-Printed Materials in Healthcare (

Reimagining Healthcare With 3D Printing (SME)

3DHEALS 2020 Virtual Medical Summit: Comprehensive Look at Craniomaxillofacial 3D Printing (

3DHEALS2018 Summit Recordings (Premium)

Download 3DHEALS2018 agenda:

The 3DHEALS2018 conference has gathered 45 cross-disciplinary influencers from all over the world to speak on the current and future trends of this burgeoning field, which aims to transform trillion-dollar industries including the manufacturing, medical device, and pharmaceutical industries. The group shares the belief that these technologies will be able to solve many healthcare challenges that existing technologies cannot, including; lowering care costs, increase access to care, and improving care outcomes. 
This two-day activity-filled event includes a Day 1 hands-on workshop to continue the company’s efforts in building and expanding end-user base among medical and dental healthcare providers, but also provide organizations with how-tos to become early adopter and users of 3D printing and bioprinting technologies. Notably, workshops include:

  • Valerie Cooper, also known as the “Denture Queen”, will lead a 1.5 hours hands-on session to teach attendees on how to create dentures with a new digital workflow that can potentially solve the current crisis where there is a lack of affordable denture providers and care.
  • Mayasari Lim from SE3D will also provide a hands-on workshop to teach attendees the basics of bioprinting, a technology that has the potential to solve current organ transplant shortage crisis.
  • Hannah Riedle from FAU Erlange-Nuremberg (Munich, Germany) will provide a 1.5 hour long hands-on workshop to share her digital workflow of generating 3D printed medical anatomical models using open source software. 
  • Erik Birkenederfrom Nixon Peabody LLP will provide an overview on how to protect intellectual properties for the entrepreneurs in this new space.

The attendees are invited to the night reception immediately following the workshops to raise money for two non-profit organizations, Limbforge and the Victoria Hand Project. The special press release for the fundraising event is here.
Day 2 is the main conference day where 40+ industry leaders and innovators will speak. The event’s keynote speaker Mr. Jeffrey Sorenson from Terarecon will start the day with his insights on how an integrated digital system composed of 3D visualization, 3D printing, and artificial intelligence will impact the future of healthcare. Two parallel tracks of expert panel presentations and QA sessions will then ensue.
Among the many topics that will be explored in-depth during the conference, notable ones include:

  • 3D printing in healthcare organizations– Include presentations from multiple institutions with variable resources, including Stanford Healthcare, Children’s Hospital of Phoenix, and Children’s Hospital Boston.
  • Legal and regulatory updates– FDA and CE updates on 3D printed medical devices, IP and liability concerns in healthcare 3D printing and bio-printing innovations. Presenting companies include UL, JNJ, ReedSmith, Nixon Peabody, and Squire Patton Boggs.
  • Digital dentistry– Include current and future trends of implementing 3D printing in dentistry and becoming part of a growing dental in-office digital manufacturing ecosystem.
  • Advanced materials updates– Include current and future material selection of biocompatible polymers and metals for 3D printed medical devices. This powerful panel includes Nag Patibandla from Applied MaterialsRik Jacobs from NextDent (now 3D Systems), Karsten Schlichter from Elkem Silicones, and Ankit Saharan from EOS.
  • Bioprinting panel– includes perspectives of how, and how soon bioprinting will impact the future of organ transplant and pharmaceutical research form a panel of bioprinting startups including Aspect BiosystemsPrellis Biologics, and pharmaceutical startup Viscient Biosciences (partner with Organovo), as well as Medtronics.
  • Orthotics and Prosthetics panel– includes updates from founders of Standard Cyborg, WiDE, the Victoria Hand Project.
  • Orthopedics panel– Includes presentations by UCSF orthopedics and AnatomicsRx, a company that successfully created the first customized sternum implant in the United States.
  • International panel – Includes individual to organizational insights on healthcare 3D printing and bioprinting innovations all over the world.

During lunchtime, the annual global pitch competition will invite 10 startups from healthcare 3D printing, bioprinting, and related 3D visualization technologies such as VR/AR to pitch in front a group of investors including GE Ventures, Asimov Ventures, Digital Industrialist, and other Silicon Valley investors.
The event will conclude with a fireside chat between Dr. Paul D’Urso, CEO of AnatomicsRx, a company that successfully created the first customized sternum implant in the United States, and Penelope Heller, the patient who successfully received the treatment. The presentation aims to provide the audience a real-life example of not only how 3D printing innovation in health care improves patient care, but also the many challenges faced by both the patients and companies to access and implement these innovations.

Media Coverage:

3DHeals 2018 to foster collaboration in medical 3D printing

Nia’s CEO Interviewed For 3DHEALS 2018 Conference

3DHEALS 2017 Summit Recordings (Premium)

The 2017 edition of 3DHEALS Global Summit was a huge success. With a co-host like UCSF, the event gathered 300+ international attendees, 45 speakers, 7 startups for the pitch competition. It also concluded with a successful fundraising event for Voices of Africa at the beautiful Autodesk gallery. The community has shown significant solidarity in collaborative work and commitment to education. Read various media write-ups about the event in the links below


Media Coverage on 3DHEALS2017

Medtech 3D printing: From a San Francisco happening to a legal limbo

3D Printing’s Legal Landscape Remains Wild, Untamed

3DHeals conference explores 3D printing and more

3DHeals: 3D printing start-ups demand skill, persistence

orthopedics sf

San Francisco: 3D Printing and AI in Orthopedics (In-Person, Hybrid) (Premium)

Join us for an exciting in-person event at 555 California Street, San Francisco, CA, USA! Discover the latest advancements in 3D technologies for orthopedics. Learn from industry experts, engage in lively discussions, and network with like-minded professionals. This event is a must-attend for anyone interested in the intersection of 3D printing and orthopedics. Don’t miss out on this opportunity to stay at the forefront of innovation in healthcare. The in-person capacity is only 30 people. Registration closes Feb 9th, 2024 for security reasons!


Craig Rosenblum

Craig Rosenblum is the President of Himed. Over 30 years of operation, Himed has become a global leader in calcium phosphate based biomaterial production and has developed proprietary plasma spray coatings and surface treatments. Craig and his team collaborate directly with dental and medical device manufacturers around the world to provide innovative biomaterial solutions. Craig discovered a unique application for MATRIX MCD® post-processing additively manufactured titanium implantable devices using Himed’s proprietary and biocompatible resorbable blast media. Himed has since formed a strategic partnership with Lithoz, a global market leader in 3D printing, to develop new bioceramic bioinks for medical 3D printing. Craig received his B.S. and M.S. degree in Materials Science & Engineering with a Biomaterials concentration from The Johns Hopkins University (Baltimore, MD). With a focus in biomaterials characterization, his groundbreaking research explored the variations in the microstructure and mechanical properties of dental enamel. These studies were the first to demonstrate the unique heterogeneous nature of enamel. Craig currently serves on The Johns Hopkins University Materials Science & Engineering Advisory Board.

Kerim Genc

Kerim serves as a Product Manager for the Simpleware Group at Synopsys, bringing over a decade of expertise to the role. Joining Simpleware in 2011 to oversee regional sales, he seamlessly navigated through progressively influential positions, including global sales and business development, culminating in his current role as a Product Manager. A highly qualified professional, Kerim earned his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University, respectively. He further solidified his academic credentials with a Ph.D. in Biomedical Engineering from Case Western Reserve University, where he utilized computational methods to investigate innovative countermeasures addressing spaceflight-induced bone loss and fracture risk.

Alyssa Huffman

Alyssa Huffman is the inventor, founder, and CEO of Allumin8. A company dedicated to bringing research-backed innovation to 3D printed orthopedic and spine hardware in an effort to increase implant survivorship and reduce the likelihood of catastrophic revisions. Allumin8’s implants (including the A8 Integr8 Porous Pedicle Screw System – not cleared for sale in the US) are designed to match the trabecular pattern of bone with the intent to study a variety of biologic therapeutics delivered through or drawn into the hardware. No change in surgical technique. No change in care. No change in pricing. Simply providing options that never before existed in hardware for the betterment of the patient. Licensing opportunities are available by contacting

Dean Hughes

dean hughes

Dean Hughes is the Regional Technical Director at Smith and Nephew Orthopedics. He earned his Bachelor’s and Master’s in Mechanical Engineering from the University of Memphis and an MBA from Christian Brothers University. Dean is a registered professional engineer in the State of Tennessee. Dean has designed, developed, and launched over 50 orthopedic implants and instruments projects with Smith and Nephew over the last 22 years. He also holds 15 US patents and several patents that are pending. Dean resides in Memphis with his wife Linda and enjoys restoring classic cars in his ‘spare’ time.


Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.